Analysis of Fas system in pulmonary injury of graft-versus-host disease after rat intestinal transplantation

Transplantation

Volumn 68, Issue 7, 1999, Pages 933-938

  Hiroyasu, Shungo ^a   Shiraishi, Masayuki ^c   Koji, Takehiko ^b   Mamadi, Toure ^c   Sugawa, Hideki ^c   Tomori, Hirofumi ^c   Muto, Yoshihiro ^c  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; GRAFT VERSUS HOST REACTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE TRANSPLANTATION; LUNG INJURY; MICROSCOPY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; GRAFT VS HOST DISEASE; IMMUNOBLOTTING; INTESTINE, SMALL; LUNG DISEASES; MALE; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED BN; RATS, INBRED LEW; RNA, MESSENGER;

EID: 0033570014     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910150-00006     Document Type: Article

References (29)

1. Clark CL, Price BA, Malcolm P, Lear PA, Wood RF. Graft versus host disease in small bowel transplantation. Br J Surg 1991; 78(9): 1077.
2. Lefrancois L. Phenotypic complexity of intraepithelial lymphocytes of the small intestine. J Immunol 1991; 147(6): 1746.
3. Blazar Br, Taylor PA, Panoskaltsis Mortari A, Barrett TA. Blue-stone JA, Vallera DA. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens. Blood 1996; 87(2): 827.
4. Via CS, Nguyen P, Shustov A, Drappa J, Elkon KB. A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 1996; 157(12): 5387.
5. Braun MY, Lowin B, French L, Acha OH, Tschopp J. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996; 183(2): 657.
6. Baker MB, Altman NH, Padack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996: 183(6): 2645.
7. Workman DL, Clancy J Jr. Interstitial pneumonitis and lymphocytic bronchiolitis/bronchitis as a direct result of acute lethal graft-versus-host disease duplicate the histopathology of lung allograft rejection. Transplantation 1994; 58(2): 207.
8. Hiroyasu S, Shiraishi M, Kusano T, Muto Y. Involvement of endothelin in graft-versus-host disease after rat small bowel transplantation. Transplant Int 1997; 10(2): 121.
9. Hagimoto N, Kuwano K, Miyazaki H, et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol 1997; 17(3): 272.
10. Sakai T, Kimura Y, Inagaki Ohara K, Kusugami K, Lynch DH, Yoshikai Y. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice [see comments]. Gastroenterology 1997; 113(1): 168.
11. Monchik G, Russell P. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971; 70(5): 693.
12. Gavrieli Y, Sherman Y, Ben SS. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119(3): 493.
13. Adams JC. Heavy metal intensification of DAB-based HRP reaction product [letter]. J Histochem Cytochem 1981; 29 (6): 775.
14. Hakuno N, Koji T, Yano T, et al. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 1996; 137(5): 1938.
15. Koji T, Kobayashi N, Nakanishi Y, et al. Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem 1994; 27(5): 459.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162(1): 156.
17. Kimura K, Wakatsuki T, Yamamoto M. A variant mRNA species encoding a truncated form of Fas antigen in the rat liver. Biochem Biophys Res Commun 1994; 198(2): 666.
18. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75(6): 1169.
19. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res 1983; 11(6): 1759.
20. Yokoi H, Natsuyama S, Iwai M, et al. Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development. Biochem Biophys Res Commun 1993; 195(2): 769.
21. Xogae S, Miyazaki M, Kobayashi N, et al. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J Am Soc Nephrol 1998; 9: 620.
22. Nishigaki K, Minatoguchi S, Seishima M, et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 1997; 29(6): 1214.
23. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154(8): 3806.
24. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182(5): 1223.
25. Schelling JR, Nkemere N, Kopp JB, Cleveland RP. Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 1998; 78(7): 813.
26. Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 1993; 5(5): 794.
27. Ortiz-Arduan A, Danoff TM, Kalluri R, et al. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996; 271 (6 Pt 2): F1193.
28. Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 1996; 173(2): 230.
29. Suzuki I, Fink PJ, Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 1998; 187(1): 123.